Related references
Note: Only part of the references are listed.5-Hydroxytryptamine-Independent Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model
Kai Zhang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Is Metabolism of (R)-Ketamine Essential for the Antidepressant Effects?
Shigeyuki Chaki
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine
Yukihiko Shirayama et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
Samuel T. Wilkinson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Mechanistic Target of Rapamycin-Independent Antidepressant Effects of (R)-Ketamine in a Social Defeat Stress Model
Chun Yang et al.
BIOLOGICAL PSYCHIATRY (2018)
What Are the Causes for Discrepancies of Antidepressant Actions of (2R, 6R)-Hydroxynorketamine?
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2018)
The development of glutamate-based antidepressants is taking longer than expected
Ricardo Garay et al.
DRUG DISCOVERY TODAY (2018)
No Sex-Specific Differences in the Acute Antidepressant Actions of (R)-Ketamine in an Inflammation Model
Lijia Chang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Role of Inflammatory Bone Markers in the Antidepressant Actions of (R)-Ketamine in a Chronic Social Defeat Stress Model
Kai Zhang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
A rapid and sensitive chiral LC-MS/MS method for the determination of ketamine and norketamine in mouse plasma, brain and cerebrospinal fluid applicable to the stereoselective pharmacokinetic study of ketamine
Hidetoh Toki et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Mechanisms of ketamine action as an antidepressant
P. Zanos et al.
MOLECULAR PSYCHIATRY (2018)
(2R,6R)-Hydroxynorketamine is not essential for the antidepressant actions of (R)-ketamine in mice
Jun-ichi Yamaguchi et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Panos Zanos et al.
PHARMACOLOGICAL REVIEWS (2018)
Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of (R,S)-ketamine and (S)-ketamine, but not (R)-ketamine
Zheng Tian et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2018)
Lack of metabolism in (R)-ketamine's antidepressant actions in a chronic social defeat stress model
Kai Zhang et al.
SCIENTIFIC REPORTS (2018)
Side-effects associated with ketamine use in depression: a systematic review
Brooke Short et al.
LANCET PSYCHIATRY (2018)
Effects of a single bilateral infusion of R-ketamine in the rat brain regions of a learned helplessness model of depression
Yukihiko Shirayama et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2017)
Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys
Kenji Hashimoto et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2017)
Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine
Kenichi Fukumoto et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
Gerard Sanacora et al.
JAMA PSYCHIATRY (2017)
Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model
Chun Yang et al.
TRANSLATIONAL PSYCHIATRY (2017)
Beyond Ketamine: New Approaches to the Development of Safer Antidepressants
Shigeyuki Chaki
CURRENT NEUROPHARMACOLOGY (2017)
(R)-Ketamine Shows Greater Potency and Longer Lasting Antidepressant Effects Than Its Metabolite (2R,6R)-Hydroxynorketamine
Chun Yang et al.
BIOLOGICAL PSYCHIATRY (2017)
A Survey of the Clinical, Off-Label Use of Ketamine as a Treatment for Psychiatric Disorders
Samuel T. Wilkinson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight
Ilina Singh et al.
LANCET PSYCHIATRY (2017)
Detrimental Side Effects of Repeated Ketamine Infusions in the Brain
Kenji Hashimoto
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Ketamine's antidepressant action: beyond NMDA receptor inhibition
Kenji Hashimoto
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Ronald S. Duman et al.
NATURE MEDICINE (2016)
Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine
Chun Yang et al.
PSYCHIATRY RESEARCH (2016)
R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity
K. Hashimoto
PSYCHOLOGICAL MEDICINE (2016)
Single-dose infusion ketamine and non-ketamine N-methyl-D-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
T. Kishimoto et al.
PSYCHOLOGICAL MEDICINE (2016)
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
D. Jeffrey Newport et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Antidepressant actions of ketamine: from molecular mechanisms to clinical practice
Lisa M. Monteggia et al.
CURRENT OPINION IN NEUROBIOLOGY (2015)
How does ketamine elicit a rapid antidepressant response?
Ege T. Kavalali et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
C. Yang et al.
TRANSLATIONAL PSYCHIATRY (2015)
R(-)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
Ji-chun Zhang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
James W. Murrough et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and Beyond
John H. Krystal et al.
BIOLOGICAL PSYCHIATRY (2013)
Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
Stereoselective and regiospecific hydroxylation of ketamine and norketamine
Zeruesenay Desta et al.
XENOBIOTICA (2012)
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes
Y Hijazi et al.
DRUG METABOLISM AND DISPOSITION (2002)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
